SEM:NYE-Select Medical Holdings Corporation (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 27.41

Change

+0.02 (+0.07)%

Market Cap

USD 1.67B

Volume

0.33M

Analyst Target

USD 22.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Select Medical Holdings Corp provides long term acute care hospital services and inpatient acute rehabilitative hospital care.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-5.03 (-1.60%)

USD 80.70B
UHS Universal Health Services Inc

-0.03 (-0.02%)

USD 11.68B
DVA DaVita HealthCare Partners Inc

-1.84 (-1.34%)

USD 11.67B
FMS Fresenius Medical Care Corpora..

+0.57 (+2.83%)

USD 11.00B
THC Tenet Healthcare Corporation

-1.23 (-0.99%)

USD 10.22B
CHE Chemed Corp

-7.65 (-1.32%)

USD 9.53B
EHC Encompass Health Corp

-0.59 (-0.69%)

USD 8.26B
AMN AMN Healthcare Services Inc

+0.08 (+0.13%)

USD 2.28B
AGL agilon health Inc

+0.21 (+4.22%)

USD 2.05B
USPH US Physicalrapy Inc

-1.67 (-1.58%)

USD 1.60B

ETFs Containing SEM

PSCH Invesco S&P SmallCap Heal.. 2.58 % 0.29 %

-0.40 (-0.18%)

USD 0.20B
RNMC First Trust Mid Cap US Eq.. 0.99 % 0.60 %

-0.10 (-0.18%)

USD 0.02B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

-0.04 (-0.18%)

USD 0.08B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.64% 65% D 90% A-
Dividend Return 0.53% 86% B+ 30% F
Total Return 17.17% 65% D 90% A-
Trailing 12 Months  
Capital Gain -10.13% 43% F 19% F
Dividend Return 1.64% 75% C 23% F
Total Return -8.49% 43% F 18% F
Trailing 5 Years  
Capital Gain 88.00% 80% B- 86% B+
Dividend Return 10.29% 100% F 40% F
Total Return 98.29% 80% B- 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 19.20% 83% B 83% B
Dividend Return 20.37% 83% B 83% B
Total Return 1.16% 50% F 28% F
Risk Return Profile  
Volatility (Standard Deviation) 51.97% 35% F 18% F
Risk Adjusted Return 39.19% 78% C+ 62% D
Market Capitalization 1.67B 71% C- 73% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 13.50 68% 55%
Price/Book Ratio 3.00 50% 28%
Price / Cash Flow Ratio 6.65 42% 52%
Price/Free Cash Flow Ratio 11.00 29% 38%
Management Effectiveness  
Return on Equity 20.22% 73% 82%
Return on Invested Capital 9.25% 67% 62%
Return on Assets 4.52% 63% 69%
Debt to Equity Ratio 278.48% 32% 11%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.